Why U.S. Physical Therapy, Inc.’s (USPH) Stock Is Down 8.63%

By Cynthia McLaughlin
December 03, 2025
Featured Tickers:

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate U.S. Physical Therapy, Inc. before investing.

In this article, we go over a few key elements for understanding U.S. Physical Therapy, Inc.’s stock price such as:

  • U.S. Physical Therapy, Inc.’s current stock price and volume
  • Why U.S. Physical Therapy, Inc.’s stock price changed recently
  • Upgrades and downgrades for USPH from analysts
  • USPH’s stock price momentum as measured by its relative strength

About U.S. Physical Therapy, Inc. (USPH)

Before we jump into U.S. Physical Therapy, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

U.S. Physical Therapy, Inc. operates and manages outpatient physical therapy clinics. The company operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

Want to learn more about U.S. Physical Therapy, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about U.S. Physical Therapy, Inc..

Learn More About A+ Investor

U.S. Physical Therapy, Inc.’s Stock Price as of Market Close

As of December 03, 2025, 1:42 PM, CST, U.S. Physical Therapy, Inc.’s stock price was $75.030.

U.S. Physical Therapy, Inc. is up 2.12% from its previous closing price of $73.470.

During the last market session, U.S. Physical Therapy, Inc.’s stock traded between $71.973 and $75.050. Currently, there are approximately 15.20 million shares outstanding for U.S. Physical Therapy, Inc..

U.S. Physical Therapy, Inc.’s price-earnings (P/E) ratio is currently at 30.9, which is high compared to the Health Care Providers & Services industry median of 22.7. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

U.S. Physical Therapy, Inc. Stock Price History

U.S. Physical Therapy, Inc.’s (USPH) price is currently up 1.6% so far this month.

During the month of December, U.S. Physical Therapy, Inc.’s stock price has reached a high of $75.050 and a low of $71.769.

Over the last year, U.S. Physical Therapy, Inc. has hit prices as high as $101.195 and as low as $62.770. Year to date, U.S. Physical Therapy, Inc.’s stock is down 15.42%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused U.S. Physical Therapy, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

One of the most common factors that can drastically impact a stock’s price is analyst upgrades and downgrades. When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. However, as of December 02, 2025,, no analysts have changed their rating of U.S. Physical Therapy, Inc.’s stock over the last month.

Additionally, you'll want to evaluate U.S. Physical Therapy, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on U.S. Physical Therapy, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

U.S. Physical Therapy, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about U.S. Physical Therapy, Inc. (USPH) by visiting AAII Stock Evaluator.

Relative Price Strength of U.S. Physical Therapy, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of December 02, 2025, U.S. Physical Therapy, Inc. has a weighted four-quarter relative price strength of -10.80%, which translates to a Momentum Score of 23 and is considered to be Weak.

Want to learn more about how U.S. Physical Therapy, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

U.S. Physical Therapy, Inc. Stock Price: Bottom Line

As of December 3, 2025, U.S. Physical Therapy, Inc.’s stock price is $75.030, which is up 2.12% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like U.S. Physical Therapy, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
O'Neil CAN SLIM Screen: 38.3% Compared to S&P 500
at only 23.3%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.